AI MARKET SCANNING

Travere Therapeutics Inc

📅 Next Catalyst: Nov 02, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +1.19%
MAX GAP RECORD +16.69%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $TVTX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 02, 2026 Earnings Release 2026-11-02 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
+10.67%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
-2.30%
Feb 19, 2026 Earnings Release 2026-02-19 (AFTER CLOSE)
+0.61%
Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE)
+16.69%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+0.99%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
-0.36%
Feb 20, 2025 Earnings Release 2025-02-20 (AFTER CLOSE)
-8.82%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.0%
Bullish Gaps (3)
Bearish Gaps (4)
Neutral / Flat (8)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $TVTX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-27 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1352m +2.65%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗